Open AccessThe value of routinely combining the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators with multiparametric magnetic resonance imaging to predict clinically significant prostate cancer remains uncertain
Author(s) -
John Yaxley,
Robert A. Gardiner
Publication year - 2018
Publication title -
ame medical journal
Language(s) - English
Resource type - Journals
ISSN - 2520-0518
DOI - 10.21037/amj.2018.10.04
Subject(s) - medicine , prostate cancer , magnetic resonance imaging , prostate , multiparametric mri , cancer , prostate cancer screening , randomized controlled trial , radiology , oncology , prostate specific antigen